Skip to main content
Puneeth Iyengar, MD, Radiation Oncology, New York, NY

Puneeth Iyengar MD


Attending and Director of the Metastatic Program, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York

Request Appointment
  • 1275 York AvenueNew York, NY 10065

  • Book by Phone+1(815) 339-8045

Overview of  Dr. Iyengar

Dr. Puneeth Iyengar is a radiation oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, William P. Clements, Jr. University Hospital, Memorial Hospital for Cancer and allied Diseases, and Children's Medical Center Dallas. He received his medical degree from Albert Einstein College of Medicine of Yeshiva University and has been in practice 12 years. He is one of 28 doctors at William P. Clements, Jr. University Hospital and one of 115 doctors at Memorial Sloan Kettering Cancer Center who specialize in Radiation Oncology. He has more than 100 publications and over 500 citings.

Education & Training

  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2006 - 2010
  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonInternship, Internal Medicine, 2005 - 2006
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 2005
  • Massachusetts Institute of Technology
    Massachusetts Institute of TechnologyB.S., 1993 - 1997

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2023 - Present
  • NJ State Medical License
    NJ State Medical License 2023 - 2027
  • NY State Medical License
    NY State Medical License 2023 - 2026
  • TX State Medical License
    TX State Medical License 2010 - 2023
  • Radiation Oncology
    American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • Educator of the Year Teaching Award ARRO (Association of Residents in Radiation Oncology), 2016
  • Translational Research Award Sidney Kimmel Cancer Research Foundation, 2013
  • President's Research Council Award Winner UT Southwestern Medical Center, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial  
    Iyengar P, Wardak Z, Gerber DE, Tumati V, Ahn C, Hughes RS, Dowell JE, Cheedella N, Nedzi L, Westover KD, Pulipparacharuvil S, Choy H, Timmerman RD, JAMA Oncol, 1/11/2018
  • Shell feature: a new radiomics descriptor for predicting distant failure after radiotherapy in non-small cell lung cancer and cervix cancer  
    Hao H, Zhou Z, Li S, Maquilan G, Folkert MR, Iyengar P, Westover KD, Albuquerque K, Liu F, Choy H, Timmerman R, Yang L, Wang J, Phys Med Biol, 1/2/2018
  • Adipocyte Xbp1s overexpression drives uridine production and reduces obesity  
    Deng Y, Wang ZV, Gordillo R, Zhu Y, Ali A, Zhang C, Wang X, Shao M, Zhang Z, Iyengar P, Gupta RK, Horton JD, Hill JA, Scherer PE, Mol Metab, 1/2/2018
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • From Surgery to Radiosurgery: New Horizons 
    Spezia, Italy - 1/1/2017
  • New Developments in Cancer Cachexia 
    Bangalore - 1/1/2012
  • Respiratory Tumors-Therapy and Biology 
    Dallas - 1/1/2011
  • Join now to see all

Press Mentions

  • Patient-Centered Approach Recommended for Oligometastatic NSCLC
    Patient-Centered Approach Recommended for Oligometastatic NSCLCMay 3rd, 2023
  • First Guideline for Treating Oligometastatic NSCLC
    First Guideline for Treating Oligometastatic NSCLCApril 28th, 2023
  • First Guideline for Treating Oligometastatic NSCLC
    First Guideline for Treating Oligometastatic NSCLCApril 28th, 2023
  • Join now to see all

Grant Support

  • Identifying the Cellular and Molecular Targets of JAK/STAT-Driven Adipose Wasting to Reverse Cancer CachexiaUT SOUTHWESTERN MEDICAL CENTER2022–2027
  • Identifying the Cellular and Molecular Targets of JAK/STAT-Driven Adipose Wasting to Reverse Cancer CachexiaUT SOUTHWESTERN MEDICAL CENTER2022–2027
  • Identifying the Cellular and Molecular Targets of JAK/STAT-Driven Adipose Wasting to Reverse Cancer CachexiaUT SOUTHWESTERN MEDICAL CENTER2022–2027
  • Identifying the Cellular and Molecular Targets of JAK/STAT-Driven Adipose Wasting to Reverse Cancer CachexiaUT SOUTHWESTERN MEDICAL CENTER2022–2027
  • LIFR-alpha/JAK/STAT3-dependent Adipose Inflammation Contributes to Obesity-Associated NAFLD - ResubmissiUT SOUTHWESTERN MEDICAL CENTER2022–2026
  • LIFR-alpha/JAK/STAT3-dependent Adipose Inflammation Contributes to Obesity-Associated NAFLD - ResubmissiUT SOUTHWESTERN MEDICAL CENTER2022–2026

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: